Next, to elucidate if reduced protein levels of catalase in CLL cells was a result of its reduced mRNA expression, we quantified catalase transcript levels in CLL cells from randomly chosen patients (n = 10) by qRT-PCR. The gene discussed is CAT; the disease is B-cell chronic lymphocytic leukemia.